Send Your Enquiry
Dr. A. V. S. Suresh
5.0 (32 Ratings)
Medical Oncologist
Continental Hospitals, Hyderabad · Hyderabad
20+ years of experience
About Dr. Sainath Bhethanabhotla
Dr. Sainath Bhethanabhotla is a well-known Medical Oncologist with over 13 years of experience, committed to delivering top-tier, personalised cancer care. He combines extensive clinical expertise with a dedication to advanced treatment options, offering hope and improved outcomes to his patients.
Why Choose Dr. Sainath?
- Comprehensive Oncological Expertise: With 13+ years of dedicated practice, Dr. Sainath has a proven track record in managing a broad spectrum of cancers, including solid tumours (breast, lung, gynaecological, gastrointestinal, genitourinary) and haematological malignancies (leukaemia, lymphoma, myeloma).
- Advanced Treatment Modalities & Specialised Focus: Dr. Sainath leverages the latest advancements, including chemotherapy, targeted therapy, immunotherapy, and precision medicine based on personalised genomic testing. He holds a special interest and deep expertise in managing Hodgkin lymphoma, particularly in paediatric and neonatal patients.
- Expertise in Complex Therapies: Highly skilled in bone marrow transplant (BMT) and cellular therapy, Dr. Sainath offers advanced treatment options for complex and challenging haematological and oncological conditions.
Location
DM, All India Institute of Medical Sciences- MD, All India Institute of Medical Sciences
- MBBS, Osmania Medical College
1. Won Sorel Catherine Prize For Best Post Graduate in Pediatrics For The Year 2012. 2. Stood 2nd in NNF Gold Medal Paper For The Year 2012(1). 3. Received Scholarship For Oral Presentation in SIOP-2015, Cape Town, South Africa For The Abstract “OUTCOME OF PEDIATRIC HODGKIN LYMPHOMA TREATED WITH ABVD: A MULTICENTRIC ANALYSIS OF 335 PATIENTS”. 4. Awarded “Abstract Achievement Award” at American Society of Hematology Meeting on Hematological Malignancies Held in Chicago on 16th,17th September ,2016 For The Abstract “Prognostic Significance of Neutrophil-Lymphocyte Ratio in Advanced Pediatric Hodgkin Lymphoma-A Multicentric Analysis of 186 Patients”
- Consultant, Care Hospitals, Banjara Hills, Hyderabad
- Consultant, Krishna Institute of Medical Sciences
- Senior Resident, MNJ Institute of Oncology and Regional Cancer Center, Hyderabad
- Senior Resident, All India Institute of Medical Sciences, New Delhi
Papers Published
- Bhethanabhotla S, Bakhshi S. Reply: Neither Post-Treatment PET-CT Nor Interim PET-CT Using Deauville Criteria Predicts Outcome In Pediatric Hodgkin Lymphoma. J Nucl Med. 2016 Dec8;IMPACT FACTOR: 7.439
+ Read More- Show Less
- Bhethanabhotla S, Jain S, Kapoor G, Mahajan A, Chopra A, Vishnubhatla S, Et Al. Outcome Of Pediatric Advanced Hodgkin Lymphoma Treated With ABVD And Predictors Of Inferior Survival: A Multicenter Study Of 186 Patients. Leuk Lymphoma. 2016 Dec 6;1–7. IMPACT FACTOR:2.644
- Bakhshi S, Bhethanabhotla S, Kumar R, Agarwal K, Sharma P, Thulkar S, Et Al. Post- Treatment PET-CT Rather Than Interim PET-CT Using Deauville Criteria Predicts Outcome In Pediatric Hodgkin Lymphoma: A Prospective Study Comparing PET-CT Versus Conventional Imaging. J Nucl Med. 2016 Oct 6; IMPACT FACTOR: 7.439
- Bhethanabhotla S, Bakhshi S. Presence Of Risk Factors Does Not Affect Outcome In Early Stage Pediatric Hodgkin Lymphoma Treated With ABVD. Ann Hematol. 2016 Nov 18; IMPACT FACTOR: 2.845
- Taywade SK, Kumar R, Bhethanabhotla S, Bal C. Role Of (18)F-FDG PET-CT In Monitoring The Cyclophosphamide Induced Pulmonary Toxicity In Patients With Breast Cancer - 2 Case Reports. Nucl Med Mol Imaging. 2016 Sep;50(3):261–5.
- Kakkar A, Rajeshwari M, Bhethanabhotla S, Kaur K, Jain D, Gogia A, Et Al. Primary Diffuse Large B-Cell Lymphoma Of The Prostate: A Report Of Two Cases With Diagnostic Considerations. J Cancer Res Ther. 2015 Dec;11(4):977–9. IMPACT FACTOR: 0.8459
- Gajendra S, Gogia A, Tanwar P, Sahoo MK, Bhethanabhotla S, Durgapal P, Et Al. Synchronous Metastatic Pulmonary Adenocarcinoma With Small Cell Lymphoma. Leuk Lymphoma. 2014 Jul;55(7):1678–80. IMPACT FACTOR: 2.644
- Bhethanabhotla S, Thukral A, Sankar MJ, Agarwal R, Paul VK, Deorari AK. Effect Of Position Of Infant During Phototherapy In Management Of Hyperbilirubinemia In Late Preterm And Term Neonates: A Randomized Controlled Trial. J Perinatol. 2013 Oct;33(10):795–9. IMPACT FACTOR: 2.183
- Kumar L, Boya RR, Pai R, Harish P, Mookerjee A, Sainath B, Et Al. Autologous Stem Cell Transplantation For Multiple Myeloma: Long-Term Results. The National Medical Journal Of India. 2016 Jul 1;29(4):192. IMPACT FACTOR: 0.786
- Bhethanabhotla, S., Tiwari, A., Sharma, M.C. Et Al. Prognostic Significance Of IL-6 In Hodgkin Lymphoma. Indian J Pediatr. 2019 Mar 4;Online First. IMPACT FACTOR: 1.046
- Patel A, Tannock I, Bhethanabhola S, Srivastva P, Biswas B, Et Al. Low-Dose Abiraterone In Metastatic Prostate Cancer: Is It Practice Changing? Facts And Facets.JCO Glob Oncol. 2020 Mar;6:382-386. IMPACT FACTOR:1.79
Send Your Enquiry
Fill in your details and our medical experts will contact you within 24 hours.
Want to consult the doctor?
Don't Ignore Your Health!
Other Top Medical Oncologist In Hyderabad
Chat
Dr. Srinivas Chakravarthy Gummaraju
5.0 (22 Ratings)
Hematologist
Apollo Hospitals, Jubilee Hills Hyderabad · Hyderabad
22+ years of experience
Dr. Rama Mohan Reddy Vada
Radiation Oncologist
Continental Hospitals, Hyderabad · Hyderabad
23+ years of experience
Dr. Amit K. Jotwani
Radiation Oncologist
Medicover Hospital, Hitec City · Hyderabad
20+ years of experience · 900+ surgeries
FAQ's About Dr. Sainath Bhethanabhotla
Where does Dr. Sainath Bhethanabhotla practice?
Dr. Sainath Bhethanabhotla practices at Star Hospital, Financial District, Star Hospitals, Hyderabad
What is the specialty of Dr. Sainath Bhethanabhotla?
Dr. Sainath Bhethanabhotla specialty is Medical Oncologist
What is the experience of Dr. Sainath Bhethanabhotla?
Dr. Sainath Bhethanabhotla is Medical Oncologist with 13 years of experience.
Chat